-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.0057.66% Upside
Humacyte, Inc. Frequently Asked Questions
-
What analysts cover Humacyte, Inc.?
Humacyte, Inc. has been rated by research analysts at Piper Sandler, BTIG, Cowen & Co. in the past 90 days.